Pathogenesis of alcohol-induced osteoporosis and its treatment: A review

Current Drug Targets

Volumn 14, Issue 13, 2013, Pages 1601-1610

  Abukhadir, Seham S ^a   Mohamed, Norazlina ^a   Mohamed, Norliza ^a  

^a UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

Author keywords

Alcohol induced; Bone mineral density; Oxidative stress; Secondary osteoporosis

Indexed keywords

ACETYLCYSTEINE; ADENOSINE TRIPHOSPHATE; ALENDRONIC ACID; ALKALINE PHOSPHATASE; ALPHA TOCOPHEROL; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CARBOXY TERMINAL TELOPEPTIDE; CYTOCHROME P450 2E1; DEOXYPYRIDINOLINE; DICKKOPF 1 PROTEIN; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; GLUTATHIONE; IBANDRONIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MAGNESIUM; NICOTINAMIDE ADENINE DINUCLEOTIDE; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; PARATHYROID HORMONE; PARATHYROID HORMONE[1-34]; PHOSPHATE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN C; UNINDEXED DRUG; VITAMIN D; BONE DENSITY CONSERVATION AGENT;

ALCOHOL CONSUMPTION; ALCOHOL INDUCED OSTEOPOROSIS; ALCOHOL LIVER DISEASE; ALCOHOLISM; BONE DISEASE; BONE INJURY; BONE MASS; BONE MINERALIZATION; CELL DAMAGE; COLLAGEN DEGRADATION; DIET SUPPLEMENTATION; GENE EXPRESSION; HORMONAL THERAPY; HUMAN; INCIDENCE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOCYTE; OSTEOPOROSIS; OXIDATIVE STRESS; PROTEIN EXPRESSION; REVIEW; RISK FACTOR; WNT SIGNALING PATHWAY; ANIMAL; BONE DENSITY; COMPLICATION; DRUG EFFECTS; MALE; OSTEOLYSIS; PATHOLOGY; RAT;

ALCOHOLISM; ANIMALS; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; BONE RESORPTION; CALCIFICATION, PHYSIOLOGIC; DIPHOSPHONATES; HUMANS; MALE; OSTEOPOROSIS; PARATHYROID HORMONE; RATS; VITAMIN D;

EID: 84889025106     PISSN: 13894501     EISSN: 18735592     Source Type: Journal    
DOI: 10.2174/13894501113146660231     Document Type: Review

References (101)

1. Stevens DA, Williams GR. Hormone regulation of chondrocytedifferentiation and endochondral bone formation. Mol Cell Endocrinol 1999; 151: 195-204.
2. Teitelbaum SL. Bone resorption by osteoclasts. Science 2000; 289:1504-8.
3. Roux S, Orcel P. Bone loss: factors that regulate osteoclast differ-entiation. Arthritis Res Ther 2000; 2: 451-6.
4. World Health Organisation, 2012, http://www.who.int/chp/top-ics/Osteoporosis.pdf.
5. Muthusami S, Ramachandran I, Muthusami B, et al. Ovariectomyinduces oxidative stress and impairs bone antioxidantsystem in adult rats. Clin Chim Acta 2005; 360: 81-6.
6. Suda N, Morita I, Kuroda T, Murota SI. Participation of oxidativestress in the process of osteoclast differentiation. Biochim Biophys Acta 1993; 1157: 318-23.
7. Yang S, Madyastha P, Bingel S, Ries W, Key L. A new superox-ide-generating oxidase in murine osteoclasts. J Biol Chem 2001; 276: 5452-8.
8. Yang Z, Collin-Osdoby P, Li L. A human homolog of the 150 kDavian osteoclast membrane antigen related to superoxide dismutase and essential for bone resorption is induced by developmental agents and opposed by estrogen in FLG 29. 1 cells. Calcif Tissue Int 1997; 60: 187-93.
9. Vant Hof RJ, Ralston SH. Nitric oxide and bone. Immunology2001; 103: 255-61.
10. Basu S, Michaëlsson K, Olofsson H, Johansson S, Melhus H. As-sociation between oxidative stress and bone mineral density. Biochem Biophys Res Commun 2001; 288: 275-9.
11. Yalin S, Bagis S, Polat G, et al. Is there a role of free oxygen radi-cals in primary male osteoporosis? Clin Exp Rheumatol 2005; 23: 689-92.
12. Cooper C, Melton LJ. Epidemiology of osteoporosis. Trends Endo-crinol Metab 1992; 3: 224-9.
13. Burge R, Dawson-Hughes B, Solomon DH, Wong JB, King A, Tosteson A. Incidence and economic burden of osteoporosisrelated fractures in the United States. J Bone Miner Res 2007; 22: 465-75.
14. Bilezikian JP. Gender specificity and osteoporosis. J Gend SpecifMed 2000; 3: 6-12.
15. Johnell O, Kanis J, Gullberg G. Mortality, morbidity, and assess-ment of fracture risk in male osteoporosis. Calcif Tissue Int 2001; 69: 182-4.
16. Chang KP, Center JR, Nguyen TV, Eisman JA. Incidence of hipand other osteoporotic fractures in elderly men and women Osteoporosis Epidemiology Study. J Bone Miner Res 2004; 19: 532-6.
17. Jiang HX, Majumdar SR, Dick DA, et al. Development and initialvalidation of a risk score for predicting in-hospital and 1-year mortality in patients with hip fractures. J Bone Miner Res 2005; 20: 494-500.
18. Scane AC, Francis RM, Sutcliffe AM, Francis MJ, Rawlings DJ, Chapple CL. Case-control study of the pathogenesis and sequelae of symptomatic vertebral fractures in men. Osteoporos Int 1999; 9: 91-7.
19. Lau E, Ong K, Kurtz S, Schmier J, Edidin A. Mortality followingthe diagnosis of a vertebral compression fracture in the Medicare population. J Bone Joint Surg Br 2008; 90: 1479-86.
20. Melton LJ 3rd, Atkinson EJ, Cooper C, O'Fallon WM, Riggs BL. Vertebral fractures predicts subsequent fractures. Osteoporos Int 1999; 10: 214-21.
21. Klotzbuecher CM, Ross PD, Landsman PB, Abbott TA 3rd, BergerM. Patients with prior fractures has an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 2000; 15: 721-39.
22. Meryn S. Undertreatment of osteoporosis in men. Arch Intern Med 2005; 165-241.
23. Khosla S, Amin S, Orwoll E. Osteoporosis in men. Endocr Rev 2008; 29: 441-64.
24. Lips P. Vitamin D deficiency and secondary hyperparathyroidismin the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 2001; 2: 477-501.
25. Khosla S, Melton LJ 3rd, Atkinson EJ, O'Fallon WM, Klee GG, Riggs BL. Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen. Endocrinol Metab Clin North Am 1998; 83: 2266-74.
26. Orwoll E, Lambert LC, Marshall LM, et al. Testosterone and estra-diol among older men. Endocrinol Metab Clin North Am 2006; 91: 1336-44.
27. Falahati-Nini A, Riggs BL, Atkinson EJ, O'Fallon WM, Eastell R, Khosla S. Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J Clin Invest 2000; 106: 1553-60.
28. Leder BZ, LeBlanc KM, Schoenfeld DA, Eastell R, Finkelstein JS. Differential effects of androgens and estrogens on bone turnover in normal men. Endocrinol Metab Clin North Am 2003; 88: 204-10.
29. Amin S, Riggs BL, Atkinson EJ, Oberg AL, Melton LJ 3rd, Khosla S. Estradiol, testosterone, and the risk for hip fractures in elderly men from the Framingham Study. Am J Public Health 2006; 119: 426-33.
30. Amin S, Riggs BL, Atkinson EJ, Oberg AL, Melton LJ 3rd, Khosla S. A potentially deleterious role of IGFBP-2 on bone density in aging men and women. J Bone Miner Res 2004; 19: 1075-83.
31. Amin S, Riggs BL, Melton LJ 3rd, Achenbach SJ, Atkinson EJ, Khosla S. High serum IGFBP-2 is predictive of increased bone turnover in aging men and women. J Bone Miner Res 2007; 22: 799-807.
32. Ebeling PR. Osteoporosis in men: New insights into aetiology, pathogenesis, prevention and management. Drugs Aging 1998; 13: 421-34.
33. Ebeling PR. Clinical practice. Osteoporosis in men. N Engl J Med 2008; 358: 1474-82.
34. Orwoll ES, Klein R. Osteoporosis in men Epidemiology, patho-physiology, and clinical characterization. Osteoporosis 2001; 1: 103-49.
35. Turner RT. Skeletal response to alcohol. Alcohol Clin Exp Res 2000; 24:1693-701.
36. Kristensson H, Lunden A, Nilsson BE. Fracture incidence anddiagnostic roentgen in alcoholics. Acta Orthop Scand 1980; 51: 205-7.
37. Yuan Z, Dawson N, Cooper GS, Einstadter D, Cebul R, Rimm AA. Effects of alcohol-related disease on hip fracture and mortality: a retrospective cohort study of hospitalized Medicare beneficiaries. Am J Public Health 2001; 91: 1089-93.
38. Chakkalakal DA. Alcohol-induced bone loss and deficient bonerepair. Alcohol Clin Exp Res 2005; 29: 2077-90.
39. Mathog RH, Toma V, Clayman L, Wolf S. Nonunion of the man-dible: an analysis of contributing factors. J Oral Maxillofac Surg 2000; 58: 746-2.
40. Carpintero P, Lopez P, Leon F, Lluch M, Montero M, Aguilera C. Men with hip fractures have poorer nutritional status and survival than women: aprospective study of 165 patients. Acta Orthop 2005; 76: 331-35.
41. Tonnesen H, Pedersen A, Jensen MR, et al. Anklefractures andalcoholism. The influence of alcoholism on morbidity aftermalleolar fractures. J Bone Joint Surg Br 1991; 73: 511-13.
42. Turner TR, Wronski TJ, Zhang M, et al. Effects of ethanol on geneexpression in rat bone: transient dose-dependent changes in mRNA levels for matrix proteins, skeletal growth factors, and cytokines are followed by reductions in bone formation. Alcohol Clin Exp Res 1998; 22: 1591-9.
43. Sampson HW, Chaffin C, Lange JL, DeFee B. Alcohol consump-tion by young actively growing rats: a histomorphometric study of cancellous bone. Alcohol Clin Exp Res 1997; 21: 352-9.
44. Nyquist F, Ljunghall S, Berglund M, Obrant K. Biochemical mark-ers ofbone metabolism after short and long time ethanol withdrawal inalcoholics. Bone 1996; 19: 51-4.
45. Laitinen K, Tahtela R, Luomanmaki K, Valimaki MJ. Mechanismsofhypocalcemia and markers of bone turnover in alcoholintoxicateddrinkers. Bone Miner 1997; 24: 171-9.
46. Sampson HW. Effect of alcohol consumption on adult and agedbone: a histomorphometric study of the rat animal model. Alcohol Clin Exp Res 1998; 22: 2029-34.
47. Wezeman FH, Emanuele MA, Emanuele N, et al. Chronic alcoholconsumption during male rat adolescence impairs skeletal development through effects on osteoblast gene expression, bone mineral density, and bone strength. Alcohol Clin Exp Res 1999; 23: 1534-42.
48. Wezeman FH, Emanuele M, Moskal SF, et al. Alendronate admini-stration and skeletal response during chronic alcohol intake in the adolescent male rat. J Bone Miner Res 2000; 15: 2033-41.
49. Peng TC, Kusy RP, Hirsch PF, Hagman JR. Ethanol inducedchanges inmorphology and strength of femurs of rats. Alcohol Clin Exp Res 1988; 12: 1655-9.
50. Hogan HA, Groves JA, Sampson HW. Long-term alcohol con-sumption in the rat affects femur cross-sectional geometry and bone tissue material properties. Alcohol Clin Exp Res 1999; 23: 1825-33.
51. Wezeman FH, Juknelis D, Frost N, Callaci HJ. Spine bone mineraldensity and vertebral body height is altered by alcohol consumption in growing male and female rats. Spine 2003; 31: 87-92.
52. Maddalozzo GF, Turner RT, Edwards CH, et al. Alcohol alterswhole body composition, inhibits bone formation, and increases bone marrow adiposity in rats. Osteoporos Int 2009; 20: 1529-38.
53. Cui Q, Wang Y, Saleh KJ, Wang GJ, Balian G. Alcohol inducedadipogenesis in a cloned bone-marrow stem cell. J Bone Joint Surg Am 2006; 88: 148-54.
54. Wezeman FH, Gong Z. Adipogenic effect of alcohol on humanbone marrow-derived mesenchymal stem cells. Alcohol Clin Exp Res 2004; 28: 1091-101
55. Malik P, Gasser RW, Kemmler G, et al. Low bone mineral densityand impaired bone metabolism in young alcoholic patients without liver cirrhosis: a cross-sectional study. Alcohol Clin Exp Res 2009; 33: 375-81.
56. Ronis MJ, Wands JR, Badger TM, de la Monte SM, Lang CH, Calissendorff J. Alcohol-induced disruption of endocrine signaling. Alcohol Clin Exp Res 2007; 31: 1269-85.
57. Chen JR, Lazarenko OP, Haley RL, Blackburn ML, Badger TM, Ronis MJ. Ethanol impairs estrogen receptor signaling resulting in accelerated activation of senescence pathways, whereas estradiol attenuates the effects of ethanol in osteoblasts. J Bone Miner Res 2009; 24: 221-30.
58. Schnitzler CM, Mesquita JM, Shires R. Cortical and trabecularbone microarchitecture and turnover in alcohol-induced chronic pancreatitis: a histomorphometric study. J Bone Miner Metab 2010; 28: 456-67.
59. Chavassieux P, Serre CM, Vergnaud P, Delmas PD, Meunier PJ. Invitro evaluation of dose-effects of ethanol on human osteoblastic cells. Bone Miner 1993; 22: 95-103
60. Cheung RC, Gray C, Boyde A, Jones SJ. Effects of ethanol on bonecells in vitro resulting in increased resorption. Bone 1995; 16: 143-7.
61. Dai J, Lin D, Zhang J, et al. Chronic alcohol ingestion inducesosteoclastogenesis and bone loss through IL-6 in mice. J Clin Invest 2000; 106: 887-95.
62. Maurel DB, Jaffre C, Rochefort GY, et al. Low bone accrual isassociated with osteocyte apoptosis in alcohol-induced osteopenia. Bone 2011; 49: 543-52.
63. Wang Y, Li Y, Mao K, Li J, Cui Q, Wang GJ. Alcohol inducedadipogenesis in bone and marrow: a possible mechanism for osteonecrosis. Clin Orthop Relat Res 2003; 410: 213-24.
64. Lorenz R, Janicke-Lorenz J. Electron microscopic observation onosteocytes of chronically alcoholized rats. Arch Orthop Trauma Surg 1983; 102: 118-22.
65. Callaci JJ, Himes R, Lauing K, Wezeman FH, Brownson K. Bingealcohol-induced bone damage is accompanied by differential expression of bone remodeling-related genes in rat vertebral bone. Calcif Tissue Int 2009; 84: 474-84.
66. Ko JY, Wang FS, Wang CJ, Wong T, Chou WY, Tseng SL. In-creased Dickkopf-1 expression accelerates bone cell apoptosis in femoral head osteonecrosis. Bone 2010; 46: 584-91.
67. Tuma DJ, Casey CA. Dangerous Byproducts of Alcohol Break-down-Focus on Adducts. Alcohol Res Health 2003; 27: 285-90.
68. Windle M. Alcohol use among adolescents and young adults. Al-cohol Res Health 2003; 27: 79-85.
69. Abrams SA. Normal acquisition and loss of bone mass. Horm Res2003; 60: 71-6.
70. Hogan HA, Sampson HW, Cashier E, Ledoux N. Alcohol con-sumption by young actively growing rats: a study of cortical bone histomorphometry and mechanical properties. Alcohol Clin Exp Res 1997; 21: 809-16.
71. Sampson HW, Perks N, Champney TH, DeFee B. Alcohol con-sumption inhibits bone growth and development in young actively growing rats. Alcohol Clin Exp Res; 20: 1375-84.
72. Chakkalakal ADA. Alcohol-induced bone disease; Alcohol caninhibit the formation of new bone cells called osteoblasts, thereby decreasing bone formation. Omaha Veterans Affairs Medical Center, 2005, Accessed at http://www.eurekalert.org/pub_releases/2005-12/ace-abd120705.php.
73. Wheeler MD, Kono H, Yin M, et al. Delivery of the Cu/Zn-superoxide dismutase gene with adenovirus reduces early alcoholinduced liver injury in rats. Gastroenterology 2001; 120: 1241-50.
74. Wheeler MD, Kono H, Yin M, et al. Overexpression of manganesesuperoxide dismutase prevents alcohol-induced liver injury in the rat. J Biol Chem 2001; 276: 36664-72.
75. Iimuro Y, Bradford BU, Yamashina S, et al. The glutathione pre-cursor L-2-oxothiazolidine-4-carboxylic acid protects against liver injury due to chronic enteral ethanol exposure in the rat. Hepatology 2000; 31: 391-8.
76. Nanji AA, Yang EK, Fogt F, Sadrzadeh SM, Dannenberg AJ. Medium chain triglycerides and vitamin E reduce severity of established experimental alcoholic liver disease. J Pharmacol ExpTher 1996; 277: 1694-700.
77. Kono H, Rusyn I, Uesugi T, et al. Diphenyl-eneiodonium sulfate, an NADPH oxidase inhibitor, prevents early alcohol-induced liver injury in the rat. Am J Physiol Gastrointest Liver Physiol 2001; 280: 1005-12.
78. Banfi Iorio EL, Corsi MM. Oxidative stress, free radicals and boneremodeling. Clin Chem Lab Med 2008; 46: 1550-5.
79. Cunningham CC, Cynthia G, Van Horn. Energy Availability andAlcohol-Related Liver Pathology. Alcohol Res Health 2003; 27: 291-9.
80. Neuman MG. Cytokines-Central Factors in Alcoholic Liver Dis-ease. Alcohol Res Health 2003; 27: 307-16.
81. Rodan GA, Fleisch HA. Bisphosphonates: mechanisms of action. JClin Invest 1996; 97: 2692-6.
82. Fleisch H. Bisphosphonates: mechanisms of action. Endocr Rev1998; 19: 80-100.
83. Cranney A, Guyatt G, Griffith L, et al. The Osteoporosis Method-ology Group, the Osteoporosis Research Advisory Group. IX: summary of meta-analyses of therapies for postmenopausal osteoporosis. Endocr Rev 2002; 23: 570-8.
84. Rogers MJ. New insights into the molecular mechanisms of actionof bisphosphonates. Curr Pharm Des 2003; 9: 2643-58.
85. Ringe JD, Farahmand P. Advances in the management of corticos-teroid-induced osteoporosis with bisphosphonates. J Clin Pharm 2007; 26: 474-84.
86. Orwoll E. Assessing Bone Density in Men. J Bone Miner Res 2000; 15: 1867-70.
87. Callaci JJ, Juknelis D, Patwardhan A, Sartori M, Frost N, Wezeman FH. The effects of binge alcohol exposure on bone resorption and biomechanical and structural properties are offset by concurrent bisphosphonate hormone treatment. Alcohol Clin Exp Res 2004; 28: 182-91.
88. Wezeman FH, Juknelis D, Himes R, Callaci JJ. Vitamin D and ibandronate prevent cancellous bone loss associated with binge alcohol treatment in male rats. Bone 2007; 41: 639-45.
89. Turner RT, Evans GL, Zhang M, Sibonga JD. Effects of parathy-roid hormone on bone formation in a rat model for chronic alcohol abuse. Alcohol Clin Exp Res 2001; 25: 667-71.
90. Callaci JJ, Juknelis D, Patwardhan AG, Wezeman FH. Binge alco-hol treatment increases vertebral bone loss following ovariectomy: compensation by intermittent parathyroid hormone. Alcohol Clin Exp Res 2006; 30: 665-72.
91. Sibonga JD, Iwaniec UT, Shogren KL, Rosen CJ, Turner RT. Effects of parathyroid hormone (1-34) on tibia in an adult rat model for chronic alcohol abuse. Bone 2007; 40: 1013-20.
92. Iwaniec UT, Trevisiol CH, Maddalozzo GF, Rosen CJ, Turner RT. Effects of low-dose parathyroid hormone on bone mass, turnover, and ectopic osteoinduction in a rat model for chronic alcohol abuse. Bone 2008; 42(4): 695-701.
93. Howe KS, Iwaniec UT, Turner RT. The effects of low dose para-thyroid hormone on lumbar vertebrae in a rat model for chronic alcohol abuse. Osteoporos Int 2011; 22: 1175-81.
94. Mercer KE, Wynne RA, Lazarenko OP, et al. Vitamin D supple-mentation protects against bone loss associated with chronic alcohol administration in female mice. J Pharmacol Exp Ther 2012; 343: 401-12.
95. Chen JR, Haley RL, Hidestrand M, et al. Estradiol protects againstethanol-induced bone loss by inhibiting up-regulation of receptor activator of nuclear factor-kB ligand in osteoblasts. J Pharmacol Exp Ther 2006; 319: 1182-90.
96. Chen JR, Lazarenko OP, Haley RL, Blackburn ML, Badger TM, Ronis MJ. Ethanol impairs estrogen receptor signaling resulting in accelerated activation of senescence pathways while estradiol attenuates the effects of ethanol in osteoblasts. J Bone Miner Res 2009; 24: 221-30.
97. Chen JR, Shankar K, Nagarajan S, Badger TM, Ronis MJ. Protec-tive effects of estradiol on ethanol-induced bone loss involve inhibition of reactive oxygen species generation in osteoblasts and downstream activation of the extracellular signal-regulated kinase/signal transducer and activator of transcription 3/receptor activator of nuclear factor-kappaB ligand signaling cascade. J Pharmacol Exp Ther 2008; 324: 50-9.
98. Chen JR, Lazarenko OP, Shankar K, Blackburn ML, Badger TM, Ronis MJ. A Role for Ethanol-Induced Oxidative Stress in Controlling Lineage Commitment of Mesenchymal Stromal Cells through Inhibition of Wnt/b-Catenin Signaling. J Bone Miner Res 2010; 25: 1117-27.
99. Lean JM, Davies JT, Fuller K, et al. A crucial role for thiol anti-oxidants in estrogen-deficiency bone loss. J Clin Invest 2003; 112: 915-23.
100. National Osteoporosis Foundation, Physician's Guide To Preven-tion and Treatment of Osteoporosis, National Osteoporosis Foundation, DC, USA, 2003.
101. Maurel DB, Boisseau N, Benhamou CL, Jaffre C. Alcohol andbone: review of dose effects and mechanisms. Osteoporos Int 2012; 23: 1-16.